Nebenwirkungen · Ixiaro
IXIARO suspension for injection Japanese encephalitis vaccine (inactivated, adsorbed) · Abschnitt 4.8 · PDF-Seite 7
HOS-209873 · Präparat HOS-154391
Frequency of adverse reactions(%) by dose/age System Organ Class 0.25 ml 0.5 ml Preferred Term N=783 N=628 2 months to <3 years 3 to <18 years Blood and Lymphatic System Disorders Lymphadenopathy 0.1 0.0 Metabolism and Nutrition Disorders Decreased appetite 8.2 1.9 Nervous System Disorders Headache 2.9 6.1 Respiratory, Thoracic and Medistinal Disorders Cough 0.5 0.3 Gastrointestinal Disorders Diarrhoea 11.9 1.4 Vomiting 7.3 1.9 Nausea 3.9 1.9 Abdominal pain 0.1 0.0 Skin and Subcutaneous Tissue Disorders Rash 6.3 1.4 Musculoskeletal and Connective Tissue Disorders Myalgia 3.0 7.1 General Disorders and Administration Site Conditions Pyrexia 28.5 10.4 Influenza like illness 10.9 2.9 Irritability 10.9 1.9 Fatigue 3.5 3.5 Injection site redness 10.0 4.1 Injection site pain 6.1 14.1 Injection site tenderness 4.2 14.7 Injection site swelling 3.6 2.2 Injection site hardening 1.2 1.9 Injection site itching 0.6 1.6 Investigations Hepatic enzymes increased 0.5 0.2
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-08T13:00:00Z · SHA-256 71332075b50a86d4e73dcb323ed59ed5191431918b32ec77b77c2a8e46d026db · Passage 3befa88c3b8ed75aa5e92ed7ecd6ee601c56bd4a16af84b6f8bc789e39b945f1 · Zeichen 2822–5133 im Abschnitt